Small molecule · Oncology / Rheumatology / Dermatology

Methotrexate

Trexall
Small moleculefits DHFR
Methotrexate seated in human DHFR, with its contacts marked in coral.
RCSB 1U72 · methotrexate in human DHFR · X‑ray, 1.9 Å (opens in a new tab)
Ile7Val8Glu30Gln35Asn64Arg70Val115Tyr121Thr136

13 polar contacts with 9 residues, each within 3.5 Å

Blocks an enzyme cancer and inflammatory cells need to copy their DNA, slowing down abnormal cell growth and calming an overactive immune system.

How it works

The drug interferes with a chemical step cells need to build and repair their DNA. Because cancer cells divide quickly, this slows their growth and can help control certain leukemias and lymphomas. At the much lower doses used for arthritis and psoriasis, methotrexate instead seems to calm an overactive immune system, though scientists don't fully understand that separate effect. In cancer treatment, doctors often follow high doses with a rescue medicine to protect healthy cells from damage.

What it’s used for

Used to treat certain blood cancers, usually alongside other chemotherapy drugs. Also used to control long-term inflammatory conditions, including rheumatoid arthritis in adults, juvenile idiopathic arthritis in children, and severe psoriasis in adults, when other treatments haven't worked well enough.

Mechanism
Dihydrofolate (antimetabolite)
Drug class
Therapeutic area
Oncology / Rheumatology / Dermatology
Structure shown
X-ray, 2005